Investigational once-weekly GLP-1 and amylin receptor agonist achieves up to 14.6% weight loss and significant blood sugar reductions
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
The program expected to commence in August 2026 will be offered across multiple specialised areas with an intake of 20-30 students per course
The webinar on World Environment Day brought together scientists, policymakers, industry representatives, and researchers to discuss the role of biotech and biomanufacturing in addressing climate change and advancing sustainable development
The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Seasoned pharma leader recognized for driving sales excellence, marketing strategy, and business growth
Subscribe To Our Newsletter & Stay Updated
